MIRA INFORM REPORT

 

 

Report Date :

15.06.2013

 

IDENTIFICATION DETAILS

 

Name :

SPANSULES PHARMATECH PRIVATE LIMITED

 

 

Registered Office :

Plot No. 59, G-3, Sri Venkateshwara, Towers, Bhagyanagar Colony, Opposite K.P.H.B Hyderabad – 500072, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

09.10.2000

 

 

Com. Reg. No.:

01-035421

 

 

Capital Investment / Paid-up Capital :

Rs. 10.150 Millions

 

 

CIN No.:

[Company Identification No.]

U24230AP2000PTC035421

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDS04126D

 

 

PAN No.:

[Permanent Account No.]

AAFCS7057K

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceuticals Formulations, Pharmaceuticals Pallets and Granules

 

 

No. of Employees :

80 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (48)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 174000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is well established company having a satisfactory track record. The company has achieved a healthy growth in its turnover during 2012. Trade relations are reported as decent. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and Conditions.   

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Guttikonda Venkata Subba

Designation :

Director

Contact No.:

91-9000544189

Date :

28.05.2013

 

 

LOCATIONS

 

Registered Office/Corporate Office :

Plot No. 59, G-3, Sri Venkateshwara Towers, Bhagyanagar Colony, Opposite K.P.H.B Hyderabad – 500072, Andhra Pradesh, India

Tel. No.:

91-40-42005216/42005217/40-40130502/23061309

Mobile No.:

91-9000544189 (Mr. Guttikonda Venkata Subba)

Fax No.:

91-40-23050443/23061979

E-Mail :

info@spansulespharma.com

Website :

http://spansulespharma.com

 

 

Factory:

Plot No.163, Subhash Nagar, IDA, Jeedmetala, Hyderabad -500055

Tel No.:

91-4023194045

Fax No.:

91-40-23095782

 

 

DIRECTORS

 

As on 29.09.2012

 

Name :

Mr. Guttikonda Venkata Subba Rao

Designation :

Managing Director

Address :

Plot No.59, G-3, Sri Venkateshwara, Towers, Bhagyanagar colony, Kukatpally, District Rangareddy, Hyderabad – 500072, Andhra Pradesh, India

Date of Birth/Age :

15.021964

Date of Appointment :

09.10.2000

Din No.:

01900749

 

 

Name :

Mrs. Guttikonda Rama Devi

Designation :

Director

Address :

Plot No.59, G-3, Sri Venkateshwara, Towers, Bhagyanagar colony, Kukatpally, District Rangareddy,Hyderabad - 500072, Andhra Pradesh, India

Date of Birth/Age :

30.03.1971

Date of Appointment :

09.10.2000

Din No.:

02019526

 

 

KEY EXECUTIVES

 

Name :

Mr. Kishore

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS

 

As on 29.09.2012

 

Names of Shareholders

No. of Shares

Percentage of Holding

Guttikonda Venkata Subba Rao

1255620

63.56

Guttikonda Rama Devi

720000

36.44

Total

1975620

100.00

 

Equity Share Break up (Percentage of Total Equity)

 

As on 29.09.2012

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceuticals Formulations, Pharmaceuticals Pallets and Granules

 

 

Products :

Drugs and Medicines 

 

 

Exports :

 

Products :

Finished Goods

Countries :

  • UK
  • USA

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

GENERAL INFORMATION

 

Customers :

Wholesalers and Retailers

 

 

No. of Employees :

80 (Approximately)

 

 

Bankers :

  • Canara Bank,  SME Branch, Plot No. 74, Prashanthi Nagar, Kukatpally, Hyderabad – 500072, Andhra Pradesh, India

 

 

Facilities :

Secured Loan

31.03.2012

31.03.2011

Long Term Borrowing

 

 

Bonds/Debentures  

9.581

2.645

Short Term Borrowing

 

 

Loans repayable on demand

34.594

15.023

Total

44.176

17.668

 

Banking Relations :

-

 

 

Auditors :

 

Name :

Rao and Siva Associates

Chartered Accountants

Address :

Plot No. 121/7, 19th Road, Vivekannanda Nagar, Colony, KukatPally, Hyderabad - 500072, Andhra Pradesh, India

Mobile No.;

9948749499/9491049499

Pan No.:

AGPPM3948Q

 

 

CAPITAL STRUCTURE

 

As on 29.09.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3000000

Equity Shares

Rs.10/- each

Rs. 30.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1975620

Equity Shares

Rs.10/- each

Rs. 19.756 Millions

 


As on 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3000000

Equity Shares

Rs.10/- each

Rs. 30.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1015000

Equity Shares

Rs.10/- each

Rs. 10.150 Millions

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.         EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

10.150

10.150

(b) Reserves & Surplus

 

22.278

19.340

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

11.066

3.947

 

 

 

 

(3) Non-current liabilities

 

 

 

(a) long-term borrowings

 

9.581

2.645

(b) Deferred tax liabilities (Net)

 

1.132

0.620

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.000

0.000

 

 

 

 

(4) Current liabilities

 

 

 

(a) Short term borrowings

 

34.595

15.023

(b) Trade payables

 

43.048

31.110

(c) Other current liabilities

 

0.494

0.361

(d) Short-term provisions

 

3.698

2.322

TOTAL

 

136.042

85.518

 

 

 

 

II.       ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

33.498

26.641

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

6.001

4.090

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

1.705

1.382

(e) Other Non-current assets

 

0.000

0.000

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

28.654

20.354

(c) Trade receivables

 

59.321

30.758

(d) Cash and cash equivalents

 

0.119

0.125

(e) Short-term loans and advances

 

6.744

2.168

(f) Other current assets

 

0.000

0.000

TOTAL

 

136.042

85.518

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

10.150

2] Share Application Money

 

 

2.247

3] Reserves & Surplus

 

 

16.900

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

29.297

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

16.347

2] Unsecured Loans

 

 

0.000

TOTAL BORROWING

 

 

16.347

DEFERRED TAX LIABILITIES

 

 

0.349

 

 

 

 

TOTAL

 

 

45.993

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

19.483

Capital work-in-progress

 

 

0.217

INVESTMENT

 

 

0.000

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

8.309

 

Sundry Debtors

 

 

22.687

 

Cash & Bank Balances

 

 

0.692

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

9.368

Total Current Assets

 

 

41.056

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditor

 

 

11.230

 

Other Current Liabilities

 

 

1.007

 

Provisions

 

 

2.526

Total Current Liabilities

 

 

14.763

Net Current Assets

 

 

26.293

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

45.993

 

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Revenue from Operations

183.778

83.588

83.222

 

 

Other Income

0.574

0.077

0.004

 

 

TOTAL                                     (A)

184.352

83.665

83.226

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of material consumed

140.965

52.887

 

 

Purchases of Stock-in-Trade

0.000

0.000

 

 

 

Changes in Inventories of finished goods Work-in-progress and stock in trade

0.000

0.000

 

 

 

Employee benefit expenses

14.421

12.590

 

 

 

Other Expenses

19.453

11.052

 

 

 

TOTAL                                     (B)

174.839

76.529

77.241

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

9.513

7.136

5.985

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

2.903

1.717

0.937

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

6.610

5.419

5.048

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

2.287

1.573

1.230

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

4.323

3.846

3.818

 

 

 

 

 

Less

TAX                                                                  (H)

1.385

1.267

1.220

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

2.938

2.579

2.598

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

19.339

16.900

14.302

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

22.277

19.339

16.900

 

 

 

 

 

 

Earnings Per Share (Rs.)

14.87

2.54

25.23

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

1.59

3.08

3.12

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

2.35

4.60

4.58

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

3.32

4.72

6.28

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.10

0.12

0.13

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

1.02.

0.53

0.56

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.16

1.09

2.78

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

---------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

--------

22]

Litigations that the firm / promoter involved in

---------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-------

26]

Buyer visit details

-------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

FINANCIAL RESULTS:

For the 12th year of operations, company has achieved a profit of Rs. 2.938 Millions on a turnover of Rs. 183.778 Millions sales. The Financial year 2011-2012 is challenging for the Company. However the current year will mark the beginning of the new growth phase centered on product diversification leading to higher returns.

 

OPERATIONS:

The Company is focused on ready to fill sustained release pellets in capsules and supplying to top 10 clients in India and exporting to many cities abroad. Now the Company is diversifying in to finished dosage form of generic and ethical. The Company has also upgraded its existing facility to WHO GMP standards located near Annaram village, Medak District A, P.

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U24230AP2000PTC035421

Name of the company

SPANSULES PHARMATECH PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Plot No. 59, G-3, Sri Venkateshwara Towers, Bhagyanagar Colony, Opposite K.P.H.B Hyderabad - 500072, Andhra Pradesh, India

Email: info@spansulespharma.com

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

90128215

Type of charge

Immovable property

Book debts

Movable property (not being pledge)

Particular of charge holder

Canara Bank,  SME Branch, Plot No. 74, Prashanthi Nagar, Kukatpally, Hyderabad – 500072, Andhra Pradesh, India

Email: cb2427@canarabank.com

Nature, description and brief particulars of the instrument(s) creating or modifying the charge

  1. Supplemental common hypothecation agreement
  2. Agreement re: advances against book debts as primary security
  3. Pronote
  4. Agreement for opening inland irrevocable letter of credit

Date of instrument Creating the charge

17.04.201

Amount secured by the charge

Rs 43.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interests:

14.50% p.a floating (Base rate + 3.75) ROI subject to change from time to time

 

Terms of Repayment:

Repayable on Demand

 

Margin:

25% on stocks and 30% on book debts

 

Extent and Operation of the charge:

Charge can be operated to the extent of the loan amount along with interest due thereon.

Short particulars of the property or asset(s) charged (including complete address and location of the property)

i)                     Hypothecation of stocks Rs. 8.412 Millions and book debts Rs. 20.751 Millions as per the stock statement as on 30.09.2011

 

ii)                   Hypothecation of plant and machinery valued Rs. 20.070 Millions as per the project report

Particulars of the present modification

Working capital limits has been increased from Rs. 15.000 Millions to Rs. 30.000 Millions (sub limit of ODBD of Rs. 20.000 Millions and sub limit of ILC/FLC Rs. 7.500 Millions) and existing term loan of Rs. 13.000 Millions remains same.

 

 

FIXED ASSETS:

 

  • Land
  • Furniture and Fixtures
  • Plant and Machinery

·         Computers

·         Buildings

·         Electrical Equipment

·         Office Equipment

·         Motor Car

·         Vehicle - Splender +

  • Air Conditioner

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.57.74

UK Pound

1

Rs. 90.64

Euro

1

Rs. 77.02

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLK

 

 

Report Prepared by :

VNT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

5

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

48

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.